The European Medicines Agency should be given a bigger role in the assessment of health risks, and the EU should extend the use of joint procurement of medical products while ensuring these procedures are transparent, according to an influential committee of the European Parliament.
It will also be important to strengthen cooperation with international organizations and third countries in exchanging knowledge and best practices in the areas of preparedness and response to health threats, particularly in
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?